GlassScriptPhysician profile
Jay L Gruhlkey
NPI 1154327047
$10,379.20
in general payments reported to CMS, 2019-2025
57 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,366 · 2020: $1,213 · 2021: $1,570 · 2022: $1,410 · 2023: $1,705 · 2024: $1,718 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,820.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,088.71 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $874.98 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $838.93 | 2019-2025 | |
| Lilly USA, LLC | $740.08 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $623.73 | 2019-2025 | |
| Amgen INC. | $574.05 | 2019-2025 | Evenity, Prolia, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $485.52 | 2019-2024 | Trintellix |
| Axsome Therapeutics, INC. | $437.42 | 2022-2025 | Auvelity, Symbravo |
| Glaxosmithkline, LLC. | $419.57 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $408.45 | 2019-2025 | Xifaxan |
| Amarin Pharma, INC. | $388.86 | 2019-2022 | |
| Allergan, INC. | $325.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $310.94 | 2019-2024 | Gardasil 9, Capvaxive, Gardasil |
| Antares Pharma, INC. | $245.29 | 2019-2025 | Xyosted |
| Exact Sciences Corporation | $237.80 | 2023-2025 | Cologuard Collection Kit |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Gruhlkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.